AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associated human diseases with the initial focus on a small molecule drug for polycystic kidney disease (PKD), a human genetic disease with 12 million patients worldwide.
View Top Employees from AceLink TherapeuticsWebsite | http://www.acelinktherapeutics.com |
Employees | 9 (2 on RocketReach) |
Founded | 2019 |
Address | 39600 Eureka Drive Ste. 151, Newark, California 94560, US |
Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular AceLink Therapeutics employee's phone or email?
Michael Babcock is the VICE PRESIDENT, RESEARCH and EARLY DEVELOPMENT of AceLink Therapeutics.
2 people are employed at AceLink Therapeutics.
AceLink Therapeutics is based in Newark, California.
The NAICS codes for AceLink Therapeutics are [541714, 541, 54, 54171, 5417].
The SIC codes for AceLink Therapeutics are [873, 87].